SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biogen
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
1686 75 0 BIIB
Emcee:  Harold Engstrom Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
611 Richard, can you help me understand what having composition of matter rights enHarold Engstrom-2/12/1998
610 Rick, IDEC has not been shy about rolling out clinicals arguably in viation of Vector1-2/11/1998
609 Harold: There appears to be no question about composition of matter. 5C8 is gscaram(o)uche-2/10/1998
608 From the IDEC 10-K: Specifically, the Company is aware of several patents andHarold Engstrom-2/10/1998
607 Scott: Thanks for the safe harbor explanation. I strongly agree with your assscaram(o)uche-2/10/1998
606 Rick, Biogen can't sue Idec for patent infringement until Idec does somethiScott-2/10/1998
605 Idec is in the clinic, with an indication that seemingly plays into BGEN strengscaram(o)uche-2/10/1998
604 It certainly looks that way today. The article was the only news I saw that couliteraryfx-2/6/1998
603 Doubtful that Science News article was the trigger to Wednesday's late sellStanley Cowen-2/6/1998
602 Science News -Jan 31- states in an article that giving uric acid to mice with literaryfx-2/5/1998
601 No clue. I only dropped by this thread to look at some of the posts on off-labBob L-2/4/1998
600 Bob- What happened today? The market was going great guns (at least most of thPuddleGlum-2/4/1998
599 The exact same language regarding off-label use appears in Group Health CooperaBob L-2/3/1998
598 Biogen Appoints Larry Gatlin, Ph.D. as Director of Pharmaceutical and AnalyticaAnnie-2/3/1998
597 Here is the H&Q upgrade news. If this shows up several times, I'm sorryPurebull-1/29/1998
596 Posted this earlier but somehow got removed. Upgrade from H&Q. Purebull. BiPurebull-1/29/1998
595 Here is the upgrade news from H&Q. Purebull Biogen -2: H&Q Cites ImprovPurebull-1/29/1998
594 Dub- The strong buy is probably the result of the stock breaking through $40 inPuddleGlum-1/29/1998
593 [ off topic, sorry for all the recent chatter ] Dave.... there is no "Biscaram(o)uche-1/29/1998
592 All, Biogen has been upgraded to "Strong Buy" by H&Q. Regards, DubM-1/29/1998
591 Bingo ! Thanks DaveDave K-1/29/1998
590 Dave: I like nice and toxic adjuvants. Put a little hole in my arm, but immunscaram(o)uche-1/29/1998
589 Sightly off topic: Rick, with your background in immune response, do you have aDave K-1/28/1998
588 My own personal bench work. I did my thesis on the immune response to chemicalscaram(o)uche-1/28/1998
587 What's the origin of your bias against cancer vaccines? Not that I have anyWilliam Nelson-1/27/1998
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News